PUBLICATION

Analysis of vertebrate vision in a 384-well imaging system

Authors
Thorn, R.J., Dombroski, A., Eller, K., Dominguez-Gonzalez, T.M., Clift, D.E., Baek, P., Seto, R.J., Kahn, E.S., Tucker, S.K., Colwill, R.M., Sello, J.K., Creton, R.
ID
ZDB-PUB-190929-13
Date
2019
Source
Scientific Reports   9: 13989 (Journal)
Registered Authors
Creton, Robbert
Keywords
none
MeSH Terms
  • Aminobenzoates/pharmacology
  • Anesthetics/pharmacology
  • Animals
  • Anti-Anxiety Agents/pharmacology
  • Behavior, Animal/drug effects
  • Behavior, Animal/physiology*
  • Diazepam/pharmacology
  • Larva/drug effects
  • Larva/physiology
  • Software
  • Swimming/physiology
  • Vision, Ocular/drug effects
  • Vision, Ocular/physiology*
  • Zebrafish/physiology*
PubMed
31562366 Full text @ Sci. Rep.
Abstract
Visual impairment affects 253 million people worldwide and new approaches for prevention and treatment are urgently needed. While small molecules with potential beneficial effects can be examined in various model systems, the in vivo evaluation of visual function remains a challenge. The current study introduces a novel imaging system for measuring visually-guided behaviors in larval zebrafish. The imaging system is the first to image four 96-well plates with a single camera for automated measurements of activity in a 384-well format. In addition, it is the first system to project moving visual stimuli and analyze the optomotor response in the wells of a 96-well plate. We found that activity is affected by tricaine, diazepam and flumazenil. Surprisingly, diazepam treatments induce a loss of visual responses, at concentrations that do not affect activity or induce hyperactivity. Overall, our studies show that the developed imaging system is suitable for automated measurements of vertebrate vision in a high-throughput format.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping